These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


273 related items for PubMed ID: 10319667

  • 1. [Efficacy of quadruple therapy in the eradication of Helicobacter pylori and prevention of recurrent duodenal ulcer].
    Ocaña Andrade E, Espinosa Soberanes JA, Mares Zambrano MA, Rosete Reyes A.
    Rev Gastroenterol Mex; 1998; 63(4):182-6. PubMed ID: 10319667
    [Abstract] [Full Text] [Related]

  • 2. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
    Bianchi Porro G, Lazzaroni M, Bargiggia S, Maconi G, Trespi E, Perego M, Alvisi C, Villani L, Luinetti O, Fiocca R, Franceschi M, Cesana B, Solcia E.
    Am J Gastroenterol; 1996 Apr; 91(4):695-700. PubMed ID: 8677931
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study].
    Multiple Center Study Group In Beijing Area, China.
    Zhonghua Yi Xue Za Zhi; 2004 Jul 17; 84(14):1161-5. PubMed ID: 15387976
    [Abstract] [Full Text] [Related]

  • 6. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.
    Hentschel E, Brandstätter G, Dragosics B, Hirschl AM, Nemec H, Schütze K, Taufer M, Wurzer H.
    N Engl J Med; 1993 Feb 04; 328(5):308-12. PubMed ID: 8419816
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recurrence of Helicobacter pylori infection and duodenal ulcer relapse, following successful eradication in an urban east Asian population.
    Khor CJ, Fock KM, Ng TM, Teo EK, Sim CS, Tan AL, Ng A.
    Singapore Med J; 2000 Aug 04; 41(8):382-6. PubMed ID: 11256345
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H.
    Hepatogastroenterology; 2004 Aug 04; 51(56):338-42. PubMed ID: 15086153
    [Abstract] [Full Text] [Related]

  • 10. Acid suppression with ranitidine plus oral triple therapy improves ulcer healing but not Helicobacter pylori eradication.
    Magalhaes AF, Macedo C, Hauck JR, Carvalhaes A, De Nucci G, Magna LA, Pedrazzoli J.
    Hepatogastroenterology; 1998 Aug 04; 45(24):2161-4. PubMed ID: 9951885
    [Abstract] [Full Text] [Related]

  • 11. Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study.
    Lazzaroni M, Perego M, Bargiggia S, Maconi G, Fiocca R, Solcia E, Franceschi M, Cesana B, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1997 Jun 04; 29(3):220-7. PubMed ID: 9646213
    [Abstract] [Full Text] [Related]

  • 12. Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.
    Wongkusoltham P, Vilaichone RK, Kullavanijaya P, Phaosawadi K, Mahachai V.
    J Med Assoc Thai; 2001 Jun 04; 84 Suppl 1():S474-80. PubMed ID: 11529378
    [Abstract] [Full Text] [Related]

  • 13. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B, Kavcic B, Gubina M, Krizman I.
    Hepatogastroenterology; 1999 Jun 04; 46(27):1746-50. PubMed ID: 10430336
    [Abstract] [Full Text] [Related]

  • 14. Five-day bismuth-free triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse.
    Coelho LG, Passos MC, Chausson Y, Castro Lde P.
    Am J Gastroenterol; 1991 Aug 04; 86(8):971-5. PubMed ID: 1858763
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J, Halle ZB, Strinić D, Kućisec N, Jandrić D, Bevanda M, Tomić M, Bilić A.
    Wien Klin Wochenschr; 2002 Jun 28; 114(12):448-53. PubMed ID: 12422579
    [Abstract] [Full Text] [Related]

  • 18. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
    Buzás György M, Székely E, Illyés G, Széles I.
    Orv Hetil; 2000 Jul 30; 141(31):1711-4. PubMed ID: 10976194
    [Abstract] [Full Text] [Related]

  • 19. Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial.
    Kaviani MJ, Malekzadeh R, Vahedi H, Sotoudeh M, Kamalian N, Amini M, Massarrat S.
    Eur J Gastroenterol Hepatol; 2001 Aug 30; 13(8):915-9. PubMed ID: 11507355
    [Abstract] [Full Text] [Related]

  • 20. A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection.
    Chan KL, Zhou H, Ng DK, Tam PK.
    J Pediatr Surg; 2001 Jul 30; 36(7):1008-11. PubMed ID: 11431766
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.